SCHEMBL4777055

SCHEMBL4777055

Cn1c(-c2ccc(Cl)cc2)nc2c(=O)[nH]c(Cc3c(F)cc(F)cc3F)nc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
HPGD P15428 3/20 0.39
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
PKM P14618 1/20 0.39
PSD A5PKW4 2/20 0.35
MAPT P10636 2/20 0.35
POLB P06746 1/20 0.35
THRB P10828 1/20 0.35
UCK2 Q9BZX2 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
ADORA3 P0DMS8 1/20 0.34
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
DHFR P00374 2/20 0.34
PDE5A O76074 1/20 0.34
PDE9A O76083 1/20 0.34
PDE1A P54750 1/20 0.34
PDE1B Q01064 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4767017 0.92 POLB (0.40) KMT2AHPGDALDH1A1KDM4EMAPT
SCHEMBL4770146 0.90 PIM1 (0.39) MEN1KMT2AHPGDALDH1A1PSD
SCHEMBL4776840 0.89 KMT2A (0.44) MEN1KMT2AHPGDALDH1A1KDM4E
SCHEMBL4776202 0.89 ALDH1A1 (0.39) MEN1KMT2AHPGDALDH1A1KDM4E
SCHEMBL4774517 0.88 MEN1 (0.42) MEN1KMT2AHPGDALDH1A1KDM4E
SCHEMBL4775960 0.86 AVPR2 (0.36) MEN1KMT2AHPGDALDH1A1POLB
SCHEMBL4772481 0.84 MEN1 (0.43) MEN1KMT2AHPGDALDH1A1KDM4E
SCHEMBL4772366 0.84 MEN1 (0.43) MEN1KMT2AHPGDALDH1A1KDM4E
SCHEMBL4776947 0.82 RNASEH1 (0.49) MEN1KMT2AHPGDALDH1A1KDM4E
SCHEMBL4776863 0.81 PIM1 (0.34) MEN1KMT2ACCNB2CCNE2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1881988-A1 2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LTD. (GB) 2008-01-30 EP disclosed
WO-2006122200-A1 2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LIMITED (GB) 2006-11-16 WO disclosed